Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
2.7600
-0.4100
(-12.93%)
As of 9:35:52 AM EST. Market Open.
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Serguei Melnik | Founder, President, Company Secretary & Executive Chairman of the Board | 175k | -- | 1974 |
| Mr. Gareth Sheridan | Founder, CEO & Director | 175k | -- | 1990 |
| Mr. Gerald Goodman | CFO & Chief Accounting Officer | 140k | -- | 1948 |
| Dr. Alan Smith Ph.D. | COO & President of 4P Therapeutics | 159k | -- | 1966 |
| Dr. Jeffrey Patrick Pharm.D. | Chief Scientific Officer | -- | -- | 1970 |
| Mr. Michael Myer | President of Pocono Pharmaceutical | 40.6k | -- | 1984 |
| Mr. Tyler Overk | Head of Active Intelligence | -- | -- | 1984 |
Nutriband Inc.
121 South Orange Avenue
Suite 1500
Orlando, FL 32801
United States
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
Corporate Governance
Nutriband Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
OMGAQ
0.0260
-16.13%
RADX Radiopharm Theranostics Limited
5.01
-5.65%
NBY NovaBay Pharmaceuticals, Inc.
0.6000
-1.65%
ELTX Elicio Therapeutics, Inc.
8.21
-0.73%
APRE Aprea Therapeutics, Inc.
2.4650
-2.57%
ADXN Addex Therapeutics Ltd
8.45
0.00%
ACTU Actuate Therapeutics, Inc. Common stock
7.07
+2.02%
OXB.L Oxford Biomedica plc
330.00
+0.61%
KTTA Pasithea Therapeutics Corp.
1.2050
-1.23%
INKT MiNK Therapeutics, Inc.
8.69
-5.54%